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Factors responsible for the emergence of arboviruses;
strategies, challenges and limitations for their control
Guodong Liang1,2, Xiaoyan Gao1,2 and Ernest A Gould3,4
Slave trading of Africans to the Americas, during the 16th to the 19th century was responsible for the first recorded emergence in the
NewWorld of two arthropod-borne viruses (arboviruses), yellow fever virus and dengue virus. Many other arboviruses have since emerged
from their sylvatic reservoirs and dispersed globally due to evolving factors that include anthropological behaviour, commercial
transportation and land-remediation. Here, we outline some characteristics of these highly divergent arboviruses, including the variety of
life cycles they have developed and the mechanisms by which they have adapted to evolving changes in habitat and host availability. We
cite recent examples of virus emergence that exemplify how arboviruses have exploited the consequences of themodern human lifestyle.
Using our current understanding of these viruses, we also attempt to demonstrate some of the limitations encountered in developing
control strategies to reduce the impact of future emerging arbovirus diseases. Finally, we present recommendations for development by
an international panel of experts reporting directly to World Health Organization, with the intention of providing internationally
acceptable guidelines for improving emerging arbovirus disease control strategies. Success in these aims should alleviate the suffering
and costs encountered during recent decades when arboviruses have emerged from their sylvatic environment.
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INTRODUCTION
Despite the announcement of the successful eradication of smallpox in
1979, the last case of rinderpest in 2008 and the current campaigns to
eradicate poliomyelitis andmeasles throughmass-immunization pro-
grammes, we still face the prospect of emerging or reemerging viral
pathogens that exploit changing anthropological behavioural pat-
terns. These include intravenous drug abuse, unregulated marketing
of domestic andwild animals, expanding human population densities,
increasing human mobility, and dispersion of livestock, arthropods
and commercial goods via expanding transportation systems. Conse-
quently, the World Health Organization concluded that acquired
immune deficiency syndrome, tuberculosis, malaria, and neglected
tropical diseases will remain challenges for the foreseeable future.1
Understandably, the high human fatality rates reported during the
recent epidemics of Ebola, severe acute respiratory syndrome and
Middle East respiratory syndrome have attracted high levels of pub-
licity. However, many other RNA viruses have emerged or reemerged
and dispersed globally despite being considered to be neglected dis-
eases.2–3 Chikungunya virus (CHIKV), West Nile virus (WNV) and
dengue virus (DENV) are three of a large number of neglected human
pathogenic arthropod-borne viruses (arboviruses) whose combined
figures for morbidity and mortality far exceed those for Ebola, severe
acute respiratory syndrome and Middle East respiratory syndrome
viruses. For instance, for DENV, the number of cases of dengue
fever/hemorrhagic fever is between 300–400 million annually, of
which an estimated 22 000 humans die.4 Moreover, in the New
World, within 12 months of its introduction, CHIKV caused more
than a million cases of chikungunya fever according to Pan American
Health Organization/World Health Organization, with sequelae that
include persistent arthralgia, rheumatoid arthritis and lifelong chronic
pain.5 Likewise, within two months of its introduction, to Polynesia,
the number of reported cases exceeded 40 0006 and is currently
believed to be approaching 200000 cases. Alarmingly, this rapid dis-
persion and epidemicity of CHIKV (and DENV or Zika virus in
Oceania) is now threatening Europe and parts of Asia through infected
individuals returning from these newly endemic regions. This is an
increasingly worrying trend. For example, in France, from 1May to 30
November, 2014, 1492 suspected cases of dengue or chikungunya fever
were reported.7 Accordingly, this review focuses on the emergence or
reemergence of arboviruses and their requirements and limitations for
controlling these viruses in the future.
VARIETIES OF ARBOVIRUSES
Arboviruses are transmitted between arthropods (mosquitoes, ticks,
sandflies, midges, bugs…) and vertebrates during the life cycle of the
virus.8Many arboviruses are zoonotic, i.e., transmissible from animals
to humans.9–10 As far as we are aware, there are no confirmed examples
of anthroponosis, i.e., transmission of arboviruses from humans to
animals.9–10 The term arbovirus is not a taxonomic indicator; it descri-
bes their requirement for a vector in their transmission cycle.11–12
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Humans and animals infected by arboviruses, may suffer diseases
ranging from sub-clinical or mild through febrile to encephalitic or
hemorrhagic with a significant proportion of fatalities. In contrast,
arthropods infected by arboviruses do not show detectable signs of
sickness, even though the virus may remain in the arthropod for life.
As of 1992, 535 species belonging to 14 virus families were registered in
the International Catalogue of Arboviruses.12 However, this estimate
is continuously increasing as advances in virus isolation procedures
and sequencingmethods impact on virus studies.Whilstmany current
arboviruses do not appear to be human or animal pathogens, this large
number of widely different and highly adaptable arboviruses provides
an immense resource for the emergence of new pathogens in the
future.
ARBOVIRUS TRANSMISSION VECTORS
In addition to evolving strategies for long-term survival, arboviruses
have an enormous choice of arthropod species potentially capable of
being infected the predominant species of which appear to be mos-
quitoes and ticks. Approximately 300 types of mosquito can transmit
arboviruses. Aedes and Culex mosquitoes are the species most fre-
quently associated with arbovirus transmission (115 and 105 types
of arbovirus, respectively).12 Ticks are also prevalent vectors, 116 dif-
ferent species are currently known to transmit arboviruses. In addi-
tion, 25 midge species have been shown to transmit arboviruses,
mainlyCulicoides (24 types) and Lasiohelea. Sandflies, blackflies, stink-
bugs, lice, mites, gadfly, and bedbugs can also transmit arboviruses.13
This diversity of species and the wide distribution of these transmis-
sion vectors explain why arboviruses are so successful in dispersing
globally via the mechanisms highlighted earlier.10–12 Arboviral dis-
eases are primarily associated with specific vectors. However, many
other arthropod species, in which viruses have been identified, may be
involved in perpetuating the virus life cycle without having been assoc-
iated with overt disease in humans or animals. For example, WNV is
typically mosquito-borne but can be vectored by many different mos-
quito species and also by ticks and other arthropods.9–10,12 Moreover,
Japanese encephalitis virus appears to be transmissible by Culex,
Anopheles, and other mosquito species, as well as midges, sandflies
and ticks. As a general rule, a specific arthropod species, is likely to
predominate during an epidemic. However, if the availability of the
vertebrate host, for example birds, becomes limited towards the end of
the summer as the birdsmigrate to warmer countries, the vectormight
switch its preference to a different vertebrate host. This is consistent
with the observation that outbreaks of West Nile fever/encephalitis in
North America often appear to occur in the late summer, following
peak incidence in birds, after they commence their migration to war-
mer regions.14 Alternatively, Aedes aegypti has adapted to the urban
environment whereas Aedes albopictus occurs more commonly in
semi-urban or rural areas. However, these are not hard and fast rules.
For example, on the French island of La Reunion, where Aedes aegypti
was not recognizably present, CHIKVwas simultaneously epidemic in
both rural and urban environments, andwas primarily associated with
Aedes albopictus.15
WORLDWIDE DISTRIBUTION OF ARBOVIRUSES AND
THEIR MOBILITY
A high proportion of arboviruses associated with human and animal
disease circulate in tropical, and subtropical regions, where mosqui-
toes, and other flying insects, tend to be abundant. However, many
arboviruses also circulate amongst wildlife species in temperate
regions of the world. Despite the global distribution of viruses such
asWNV, dengue virus, bluetongue virus and now CHIKV, most other
arboviruses are generally endemic to specific regions of the world. For
example, mosquito-borne Japanese encephalitis virus is prevalent in
India, Central and Southeast Asia, largely due to the prevalence of
highly competentCulex tritaeniorhynchusmosquito species and inten-
sely farmed pigs which act as amplifying hosts for the virus and,
importantly, the mosquitoes.16–17 In Southeast Asia, rice cultivation
with enormous areas of paddy fields also attracts migratory birds and
provides ideal breeding areas for the mosquitoes which transmit the
virus to the birds, ensuring virus dispersion over large areas of Asia.18
In contrast, tick-borne encephalitis virus occurs mainly in northern
temperate regions which are the primary habitats of Ixodes species
ticks (forests etc.).19 Nevertheless, even within this relatively localized
distribution of arboviruses, dispersion to distant locations occurs via
animal or vector migration. As an example, Powassan virus, a close
relative of tick-borne encephalitis virus, is found in Far East Asia and
also in Canada.19 In contrast, Rift Valley fever virus (RVFV) was
localized in Africa but in 1977, it was introduced to the Middle East,
where it caused thousands of human infections, with an estimated 598
deaths, during a single epidemic.20
ARBOVIRUSES AND RELATED INFECTIOUS DISEASES
More than 100 species of arbovirus that cause human/animal or zoo-
notic diseases have been identified.12 Four virus families, Togaviridae,
Flaviviridae, Bunyaviridae and Reoviridae, contain most of the arbo-
viruses that cause human/animal diseases.12 Arbovirus infections are
not always clinically obvious and often resolve spontaneously after 1–2
weeks. However, some arboviral infections result in high fever, hemor-
rhage, meningitis, encephalitis, other serious clinical symptoms, and
even death. Therefore, they cause a large social and economic burden.
A summary listing the arboviruses associated with human diseases and
their geographic distributions was published previously.21
ARBOVIRUS SURVIVAL STRATEGIES
Arboviruses have evolved a wide variety of strategies to ensure their
long-term success, dispersal and survival. They associate with specific
arthropods and exhibit distribution characteristics that reflect the
environmental preferences of these particular species. However, once
an epidemic has run its course, the virus survives via its sylvatic life
cycle which may involve a wide variety of species currently not iden-
tified. Alternatively, arboviruses can be maintained for months or
maybe even years in mosquito eggs which remain dormant until the
rainy season triggers hatching of the new, healthy but infected mos-
quito larvae.21 Eggs can also provide a long term reservoir for tick-
borne arboviruses but in many cases the viruses exploit the extended
life cycle of some tick species, surviving for years through the trans-
stadial stages, reproducing at low levels.21 This long-term survival
strategy is also enhanced by non-viraemic transmission during which
infected and non-infected ticks co-feed on small animals in the forests.
Non-viraemic transmission provides an efficient mechanism for
transmission of the virus directly between ticks, without necessarily
infecting the vertebrate host. Whilst co-feeding is taking place, virus
infectivity in the tick salivary glands may increase by orders of mag-
nitude presumably increasing virus transmission efficiency between
the ticks.22 A similar non-viraemic co-feeding transmission process
involving mosquitoes and blackflies, has also been described forWNV
and vesicular stomatitis virus.23 Alternatively some insect-specific fla-
viviruses exist in the form of DNA when they infect insect cells.24
Diverse sequences have been discovered that appear to be related to
insect-specific flaviviruses, amplified from mosquitoes, belonging to
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the culicine genera Culex, Aedimorphus, Ochlerotatus and/or Stegomyia.
Many of these sequences may represent DNA integrations into mos-
quito genomes.25–34 Moreover, sRNAs related to WNV in apparently
uninfected Culexmosquitoes have also been identified.35 Whilst there is
no current evidence that such forms of DNA, provide a long-term
arbovirus survival strategy, the similarity with other viruses that use
DNA intermediates and episomal DNA should not be ignored. These
and other diverse survival strategies provide safe havens for their long-
term survival from which they can reemerge to cause epidemics
amongst human and animal populations.
DETERMINANTS OF ARBOVIRUS EMERGENCE
Changing anthropological behaviour, climate change and high muta-
tion frequency are important determinants of arbovirus emergence.
Arboviruses adapt readily to new susceptible hosts by alteration of
receptor specificity, transmission efficiency, antigenicity, and eco-
logical and environmental conditions. Humans, livestock and/or do-
mestic animals are not an essential part of this arbovirus life cycle.
Therefore, unlike, smallpox virus, measles virus or poliovirus, arbo-
virus disease control based on humans, livestock and/or domestic
animals cannot eradicate the arbovirus. Consequently, the reservoir
for arboviruses in wild species places a limitation on our ability to
control disease emergence. For instance, CHIKV was a zoonotic arbo-
virus that cycled harmlessly between simians and mosquitoes in the
African tropical forests causing localized outbreaks of polyarthralgia
in humans. It also occasionally ‘‘escaped’’ to Asia gradually becoming
zoonotic. However, prior to 2005, CHIKV was rarely an epidemic
arbovirus until a mutation occurred in the gene encoding the surface
protein of the African strain which increased its capacity to infect,
reproduce and be transmitted by the striped Asian ‘‘Tiger’’ mosquito
Aedes albopictus.36 Coincidentally this mosquito species has gradually
dispersed westwards and CHIKV is now a major global human epi-
demic pathogen throughout Asia.5 Moreover, on 6 December 2013, it
was reported to have crossed the Atlantic Ocean, reaching the French
Caribbean island of Saint Martin from where it dispersed to the
Americas.37 It also dispersed eastwards from southern Asia, reaching
Polynesia by October 2014.6 Worryingly, CHIKV is now frequently
being introduced into non-endemic Europe and northern Asia by
incoming humans infected in the Americas and Polynesia. In the
Americas, WNV, was first reported in New York in August 1999,38
following a hot and humid summer andmany publications describe its
emergence and dispersal.21,39–41 In contrast with CHIKV, the major
determinant for the dispersal of WNV, throughout North America,
over a period of five years was primarily birds and their associated
Culexmosquito species.36 The dispersal and increasing epidemicity of
dengue fever/dengue hemorrhagic fever which is confined to humans
in the tropics, sub-tropics and southern temperate regions, can gen-
erally be attributed to human and Aedes aegypti population density
increase during the past century, resulting from intensive urbanization
and the influence of increased transportation of humans, commercial
goods, livestock and major military movements across the oceans.42
On the other hand, RVFV is enzootic and confined to a wide range of
animals, mosquitoes and sandflies throughout Africa and the Arabian
Peninsula. Generally, the virus circulates without causing major dis-
ease outbreaks which usually arise following periods of rainfall when
herded ruminants are introduced to RVFV-endemic areas. Two
important factors are believed to have influenced the epidemiology
of RVFV, firstly, major irrigation projects and secondly, the El Nin˜o
effect.43 In each case, cited above, a combination of two or more of the
factors identified earlier have had an important influence on the
appearance of these emerging arboviruses in new territories and/or old
territories. Other recently emerging arboviruses, not included in this brief
outline, include, Zika virus in Oceania, bluetongue virus and Schmal-
lenberg virus in northern Europe and Bagaza virus in Spain.44–47
STRATEGIES FOR ARBOVIRUS CONTROL
The concept of arthropod-borne disease transmission was born out of
the studies of a physician, Josiah Clark,48 and 40 years later developed
by Carlos Finlay49 who proposed mosquitoes as the agents for trans-
mission of yellow fever. Subsequently, empirical methods, such as
mosquito eradication, which was used very successfully in Cuba,50
and the development of a yellow fever vaccine has protected millions
of humans from potentially fatal infection by yellow fever virus.51–53
Now, in the 21st century genetically engineered live attenuated vac-
cines can be manufactured within months, to protect humans against
the ravages of pandemic influenza and other virus diseases. Moreover,
a spectrum of antiviral molecules has been developed to treat humans
dying from infection with human immunodeficiency virus and several
antiviral drugs have also been developed against other viruses. Does
this mean that if we develop vaccines and antiviral drugs to prevent or
treat humans against infection by pathogenic arboviruses we will
resolve the challenges associated with emerging arboviruses? Regret-
tably it is not that simple! It is a remarkable fact that in the future,
because of their high mutation rates, many new pathogenic arbo-
viruses will emerge even though they do not currently exist as epi-
demic strains in the sylvatic environment. It is also becoming clear,
from early results of genome sequencing, that mosquitoes carry large
numbers of known and unknown viruses that infect humans, pri-
mates, mammals, birds, insects, and plants.53–54 Therefore, should
we attempt global eradication of arthropods? The answer is a definite
no. This would have a catastrophic impact on the survival of many
wildlife species, as first became apparent when dichlorodiphenyltri-
chloroethane was used widely as a general insect control agent rather
than being precisely targeted to relevant mosquito species.55 However,
implementation of temporary localized arthropod control measures
during epidemics, for example in high density urbanized areas, can
still play an important but transient role in reducing the impact on
humans and animals of emerging arboviruses.
CHALLENGES AND LIMITATIONS IMPOSED BY
PATHOGENIC ARBOVIRUS
The breadth and depth of arbovirus surveillance differs regionally, and
several areas lack surveillance altogether. There is also a lack of inter-
disciplinary expertise on arbovirus diseases and understanding their
vectors, and epidemiology. In addition, only a small number of arbo-
viral diseases can be prevented using vaccines or specific antiviral
drugs, and there are few validated diagnostic reagents, with which to
monitor disease progress and control. Until such disease control
reagents become available, the most effective alternative is to focus
on practical procedures to reduce risks of exposure to arthropods.
CONCLUSIONS AND RECOMMENDATIONS FOR THE
DEVELOPMENT OF ARBOVIRUS CONTROL STRATEGIES
It is clear that we are now entering a period in virological discovery that
will reveal a ‘‘Pandora’s box’’ of new viruses with unique characteristics,
which circulate in the ecosystem and will potentially lead to the evolu-
tion of novel pathogenic arboviruses. Future disease control strategies
must therefore recognize this and be planned accordingly. What are the
major objectives that need to be addressed if we are to win the war
against these versatile viruses that appear to have an infinitesimal variety
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of strategies to confuse and disorganize our ability to bring them under
control? (i) Develop vaccines to reduce the incidence of disease caused
by known viruses; (ii) develop therapeutic drugs to treat clinical diseases
caused by known viruses; (iii) develop unified vector-controlled strat-
egies that will not unduly threaten the survival of wildlife species but
locally will reduce the risk of disease in humans and animals; (iv)
develop universal teaching/training courses to be taught worldwide,
to provide cores of expertise to implement these policies; (v) encourage
the strengthening of levels of cooperation between academia and drug
and vaccine development companies; (vi) encourage the development
of research programmes to understand the underlying mechanisms of
arboviral pathogenicity, evolution, emergence and dispersal; (vii)
develop, at the international level, public health measures to inform
and educate citizens in local arboviral disease control measures, includ-
ing monitoring and reporting; (viii) implement measures to improve
monitoring procedures at borders, harbours, airports to reduce the
influx of arthropods to new countries; (ix) develop unified public health
strategies for arboviral disease control; (x) simplify the procedures for
establishing safety and efficacy of antiviral drugs; (xi) establish an inter-
national committee of experts charged with the objective of reviewing
global arthropod control strategies; (xii) develop and implement inter-
nationally acceptable and user-friendly guidelines for avoiding exposure
to the different types of arthropod likely to carry human pathogens.
This is undoubtedly an incomplete list of recommendations and
probably some recommendations cannot easily be implemented.
Nevertheless, the list provides the building blocks for a unified strategy
on which to develop methods that will reduce the high morbidity and
mortality rates due to human or animal arbovirus infections. Finally, we
also have to recognise that arboviruses and arbovirus-related viruses
infect more than just humans, invertebrates and land-based animals.
They also infect plants, fish and marine animals. These relatively new
discoveries also need to be accommodated if arboviral disease strategies
are to be developed in a rational and unified manner. The lesson of the
past is that human endeavour is at its best in the face of adversity. Let
this be the mantra for arbovirus disease control in the future!
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